PDSB logo

PDS Biotechnology (PDSB) EBITDA

Annual EBITDA

-$40.12 M
+$612.30 K+1.50%

December 31, 2023

Summary

Performance

1-Year Change

+1.5%

3-Year Change

-169.53%

5-Year Change

+4.58%

15-Year Change

+21.45%

PDSB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.09%
PDSB annual EBITDA is higher than 37.09% of companies in Healthcare sector

High & Low

All-time High

-$7.25 M

3-Year Low

-$40.74 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PDSB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
PDSB next annual earnings announcement is scheduled for Mar 27, 2025

OtherPDSBprofitabilitymetrics:

Annual Revenue

-
PDSB annual revenue value is unknown

Annual Net Income

-$42.94 M
PDSB annual net profit is -$42.94 million

Annual EBIT

-$40.14 M
PDSB annual earnings before interest & taxes is -$40.14 million

Annual EPS

-$1.39
PDSB annual earnings per share is -$1.39

Quarterly EBITDA

-$9.51 M
-$1.50 M-18.78%

September 30, 2024

Summary

Performance

3-Month Change

-18.78%

1-Year Change

+2.18%

3-Year Change

+20.39%

5-Year Change

+20.39%

PDSB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.03%
PDSB quarterly EBITDA is higher than 37.03% of companies in Healthcare sector

High & Low

All-time High

$6.84 M
PDSB quarterly EBITDA is currently -239.06% below its historical high of $6.84 million

3-Year Low

-$18.22 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PDSB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
PDSB next earnings announcement is scheduled for Mar 27, 2025

OtherPDSBprofitabilitymetrics:

Quarterly Revenue

-
PDSB quarterly revenue value is unknown

Quarterly Net Income

-$10.73 M
PDSB quarterly net profit is -$10.73 million

Quarterly EBIT

-$9.51 M
PDSB quarterly earnings before interest & taxes is -$9.51 million

Quarterly EPS

-$0.29
PDSB quarterly earnings per share is -$0.29

TTM EBITDA

-$36.65 M
+$269.00 K+0.73%

September 30, 2024

Summary

Performance

3-Month Change

+0.73%

1-Year Change

+8.65%

3-Year Change

+20.11%

5-Year Change

+20.11%

PDSB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.8%
PDSB TTM EBITDA is higher than 37.8% of companies in Healthcare sector

High & Low

All-time High

-$3.46 M

3-Year Low

-$48.62 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PDSB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
PDSB next earnings announcement is scheduled for Mar 27, 2025

OtherPDSBprofitabilitymetrics:

TTM Revenue

-
PDSB TTM revenue value is unknown

TTM Net Income

-$40.56 M
PDSB TTM net profit is -$40.56 million

TTM EBIT

-$36.67 M
PDSB TTM earnings before interest & taxes is -$36.67 million

TTM EPS

-$1.17
PDSB TTM earnings per share is -$1.17

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$40.12 M
PDSB annual EBITDA is -$40.12 million

Annual Net Income

-$42.94 M
PDSB annual net profit is -$42.94 million

Annual Interest Expense

$4.21 M
PDSB annual interest expense is $4.21 million

Annual Income Tax

-$1.41 M
PDSB annual income tax is -$1.41 million

Annual D&A

$17.40 K
PDSB annual depreciation & amortization is $17.40 thousand

PDSB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1.5%+2.2%+8.7%
3 y3 years-169.5%+20.4%+20.1%
5 y5 years+4.6%+20.4%+20.1%

PDSB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-87.2%+1.5%-50.5%+47.8%-71.0%+24.6%
5 y5-year-453.6%+1.5%-224.2%+47.8%-405.7%+24.6%
alltimeall time-453.6%+21.4%-239.1%+76.3%-958.6%+28.3%

PDS Biotechnology EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.51 M(+18.8%)
-$36.65 M(-0.7%)
Jun 2024
-
-$8.00 M(-15.1%)
-$36.92 M(-9.6%)
Mar 2024
-
-$9.42 M(-3.0%)
-$40.86 M(+1.8%)
Dec 2023
-$40.12 M(-1.5%)
-$9.72 M(-0.6%)
-$40.12 M(-17.5%)
Sep 2023
-
-$9.78 M(-18.1%)
-$48.62 M(+6.0%)
Jun 2023
-
-$11.94 M(+37.4%)
-$45.88 M(+12.0%)
Mar 2023
-
-$8.69 M(-52.3%)
-$40.95 M(+0.5%)
Dec 2022
-$40.74 M(+90.1%)
-$18.22 M(+159.3%)
-$40.74 M(+41.3%)
Sep 2022
-
-$7.03 M(+0.1%)
-$28.84 M(+0.2%)
Jun 2022
-
-$7.02 M(-17.2%)
-$28.77 M(+7.1%)
Mar 2022
-
-$8.47 M(+34.1%)
-$26.86 M(+25.3%)
Dec 2021
-$21.43 M(+44.0%)
-$6.32 M(-9.3%)
-$21.43 M(+12.0%)
Sep 2021
-
-$6.96 M(+36.4%)
-$19.14 M(+19.0%)
Jun 2021
-
-$5.10 M(+67.5%)
-$16.08 M(+15.6%)
Mar 2021
-
-$3.05 M(-24.3%)
-$13.91 M(-6.6%)
Dec 2020
-$14.89 M(+105.4%)
-$4.02 M(+3.1%)
-$14.89 M(-3.2%)
Sep 2020
-
-$3.90 M(+33.1%)
-$15.38 M(-10.6%)
Jun 2020
-
-$2.93 M(-27.2%)
-$17.20 M(-5.0%)
Mar 2020
-
-$4.03 M(-10.9%)
-$18.11 M(+149.9%)
Dec 2019
-$7.25 M
-$4.52 M(-21.0%)
-$7.25 M(-83.1%)
Sep 2019
-
-$5.72 M(+48.9%)
-$42.78 M(+13.3%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$3.84 M(-156.2%)
-$37.77 M(+9.5%)
Mar 2019
-
$6.84 M(-117.1%)
-$34.48 M(-18.0%)
Dec 2018
-$42.05 M(-17.7%)
-$40.06 M(+5597.3%)
-$42.05 M(+135.6%)
Sep 2018
-
-$703.10 K(+25.6%)
-$17.85 M(-35.8%)
Jun 2018
-
-$560.00 K(-23.3%)
-$27.78 M(-30.8%)
Mar 2018
-
-$729.70 K(-95.4%)
-$40.16 M(-21.4%)
Dec 2017
-$51.08 M(+29.8%)
-$15.85 M(+49.0%)
-$51.08 M(+10.9%)
Sep 2017
-
-$10.64 M(-17.7%)
-$46.06 M(+0.6%)
Jun 2017
-
-$12.93 M(+11.0%)
-$45.78 M(+8.9%)
Mar 2017
-
-$11.65 M(+7.5%)
-$42.04 M(+6.8%)
Dec 2016
-$39.36 M(+39.0%)
-$10.84 M(+4.6%)
-$39.36 M(+5.3%)
Sep 2016
-
-$10.36 M(+12.6%)
-$37.38 M(+1.2%)
Jun 2016
-
-$9.20 M(+2.5%)
-$36.93 M(+11.8%)
Mar 2016
-
-$8.97 M(+1.4%)
-$33.02 M(+16.6%)
Dec 2015
-$28.32 M(+125.1%)
-$8.85 M(-10.6%)
-$28.32 M(+22.7%)
Sep 2015
-
-$9.90 M(+87.0%)
-$23.08 M(+38.7%)
Jun 2015
-
-$5.29 M(+24.0%)
-$16.64 M(+46.7%)
Mar 2015
-
-$4.27 M(+18.2%)
-$11.34 M(+60.4%)
Dec 2014
-$12.58 M(+71.5%)
-$3.61 M(+4.3%)
-$7.07 M(+104.3%)
Sep 2014
-
-$3.46 M
-$3.46 M
Dec 2013
-$7.33 M
-
-

FAQ

  • What is PDS Biotechnology annual EBITDA?
  • What is the all time high annual EBITDA for PDS Biotechnology?
  • What is PDS Biotechnology annual EBITDA year-on-year change?
  • What is PDS Biotechnology quarterly EBITDA?
  • What is the all time high quarterly EBITDA for PDS Biotechnology?
  • What is PDS Biotechnology quarterly EBITDA year-on-year change?
  • What is PDS Biotechnology TTM EBITDA?
  • What is the all time high TTM EBITDA for PDS Biotechnology?
  • What is PDS Biotechnology TTM EBITDA year-on-year change?

What is PDS Biotechnology annual EBITDA?

The current annual EBITDA of PDSB is -$40.12 M

What is the all time high annual EBITDA for PDS Biotechnology?

PDS Biotechnology all-time high annual EBITDA is -$7.25 M

What is PDS Biotechnology annual EBITDA year-on-year change?

Over the past year, PDSB annual EBITDA has changed by +$612.30 K (+1.50%)

What is PDS Biotechnology quarterly EBITDA?

The current quarterly EBITDA of PDSB is -$9.51 M

What is the all time high quarterly EBITDA for PDS Biotechnology?

PDS Biotechnology all-time high quarterly EBITDA is $6.84 M

What is PDS Biotechnology quarterly EBITDA year-on-year change?

Over the past year, PDSB quarterly EBITDA has changed by +$212.20 K (+2.18%)

What is PDS Biotechnology TTM EBITDA?

The current TTM EBITDA of PDSB is -$36.65 M

What is the all time high TTM EBITDA for PDS Biotechnology?

PDS Biotechnology all-time high TTM EBITDA is -$3.46 M

What is PDS Biotechnology TTM EBITDA year-on-year change?

Over the past year, PDSB TTM EBITDA has changed by +$3.47 M (+8.65%)